Gilead paused enrollment and terminated the trial due to safety concerns, following an FDA partial clinical hold on magrolimab studies in solid tumors. CD47 expression ... Patients with metastatic non ...

Certain chronic conditions that affect the lungs, such as asthma and chronic obstructive pulmonary disease (COPD), can have ...

NYU Langone’s Dr. Stephanie Chang opens up to PEOPLE about performing the breakthrough procedure on 57-year-old Cheryl ...

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...

Cancer research is a rapidly evolving field, with a focus on understanding the complex mechanisms underlying tumor biology.

As technology has improved, our treatment options have improved, and lung cancer treatment has become very personalized.

American Lung Association’s ‘State of Lung Cancer’ report reveals stark differences in survival, screening and treatment across states ...

Genprex (GNPX) announced it has entered into an exclusive license agreement with the University of Michigan, granting Genprex a worldwide, ...

The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.

This data supports the potential use of RTNova to target every metastatic site in multiple oncology indications including metastatic lung cancer. RTNova is uniquely ... By incorporating enveloped ...

Detecting tumor infiltration during surgery has been a vital concern for over a century. Despite advances in healthcare, the ...